Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men
The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Both estrogens and androgens play important roles in skeletal development and maintenance in men. The relative importance of estrogens and androgens in male bone metabolism, however, remains undefined. Anastrozole is an oral aromatase inhibitor that decreases estrogen production and increases androgen production in men. Currently, anastrozole is being investigated as a potential agent for the treatment of hypogonadism in aging men. Because anastrozole lowers estrogen levels and raises androgen levels, its effect on bone metabolism is difficult to predict. To assess the effects of anastrozole on bone turnover, we randomized 37 elderly (ages 62-74) mildly hypogonadal men (serum testosterone <350 ng/dl) to receive either anastrozole 1 mg daily (n=12), anastrozole 1 mg twice weekly (n=11), or daily placebo (n=14) for 12 weeks. Serum gonadal steroid levels, serum and urine biochemical markers of bone turnover, serum osteoprotegerin, and total body bone mineral density were measured at baseline and week 12. Mean serum levels of total and bioavailable testosterone increased substantially in both treated groups. Specifically, mean +/- SD bioavailable testosterone levels increased from 99+/-31 ng/dl to 207+/-65 ng/dl in the group receiving 1 mg of anastrozole daily and from 115+/-37 ng/dl to 178+/-55 ng/dl in the subjects receiving 1 mg of anastrozole twice weekly ( p <0.001 vs placebo for both groups). Serum estradiol levels decreased modestly in both treated groups (from 26+/-8 pg/m…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment with anastrozole daily for 6 months, however, did not result in a significant improvement compared with placebo [67].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [67]
In the citing paper
“Results from the Leder trial reported no change in markers of bone turnover, despite greater mean reductions in estradiol”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [125]
In the citing paper
“while Burnett-Bowie’s group identified significant reductions in bone mineral density with therapy.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [125]
In the citing paper
“Although one publication of men undergoing anastrozole therapy over a 3-month period demonstrated no significant change in markers of bone resorption, a subsequent 12-month study demonstrated direct radiologic evidence of bone mineral density loss despite unchanged markers of bone resorption.125, 126”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [125]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 1×
“Furthermore, because estrogen replacement increases cardiovascular risk [28,29] and impairs cognitive function [30–32] in women, it is possible that aromatase inhibition may have unique benefits compared with traditional testosterone replacement in men in these areas as well.”
BackgroundLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930 · cited 1×
“Furthermore, because estrogen replacement increases cardiovascular risk [28,29] and impairs cognitive function [30–32] in women, it is possible that aromatase inhibition may have unique benefits compared with traditional testosterone replacement in men in these areas as well.”
BackgroundFeldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 1×
“As men age there is a slow, steady decline in gonadal androgen production leading to a high incidence of hypogonadism [1–4].”
BackgroundMorishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“As men age there is a slow, steady decline in gonadal androgen production leading to a high incidence of hypogonadism [1–4].”
BackgroundRapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930 · cited 1×
“Furthermore, because estrogen replacement increases cardiovascular risk [28,29] and impairs cognitive function [30–32] in women, it is possible that aromatase inhibition may have unique benefits compared with traditional testosterone replacement in men in these areas as well.”
BackgroundTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791 · cited 1×
“Androgen replacement clearly increases BMD in profoundly hypogonadal men [39–42] and older men with mild hypogonadism (such as those enrolled in this study) [11].”
BackgroundSelf-citationEffects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768 · cited 1×
“Some studies have shown improvements in these parameters with androgen replacement [11–17].”
BackgroundFalahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757 · cited 2×
“Others have reported similar results [21].”
BackgroundPamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696 · cited 1×
“Gonadal steroid deprivation increases bone resorption relative to bone formation leading to bone loss [36–38].”
BackgroundSelf-citationHofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.9.7131 · Cited by 692 · cited 1×
“[73,74].”
Bone Loss and Bone Size after Menopause
Ahlborg, H. G., Johnell, O., Turner, C. H., Rannevik, G., & Karlsson, M. K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022464 · Cited by 643
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 625 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundLong-term effect of testosterone therapy on bone mineral density in hypogonadal men
Behre, H. M., Kliesch, S., Leifke, E., Link, T. M., & Nieschlag, E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4163 · Cited by 559 · cited 1×
“Androgen replacement clearly increases BMD in profoundly hypogonadal men [39–42] and older men with mild hypogonadism (such as those enrolled in this study) [11].”
BackgroundEndogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study
Greendale, G. A., Edelstein, S., & Barrett-Connor, E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1833 · Cited by 553 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundEffect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2647 · Cited by 531 · cited 1×
“Some studies have shown improvements in these parameters with androgen replacement [11–17].”
BackgroundKhosla, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3555 · Cited by 522 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundAmory, J. K., Watts, N. B., Easley, K. A., Sutton, P. R., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031110 · Cited by 475 · cited 1×
“Androgen replacement clearly increases BMD in profoundly hypogonadal men [39–42] and older men with mild hypogonadism (such as those enrolled in this study) [11].”
BackgroundEffects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 463 · cited 1×
“Some studies have shown improvements in these parameters with androgen replacement [11–17].”
BackgroundEffect of Testosterone Treatment on Bone Mineral Density in Men Over 65 Years of Age
Snyder, P. J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1966 · Cited by 460 · cited 1×
“Some studies have shown improvements in these parameters with androgen replacement [11–17].”
BackgroundSlemenda, C. W., Longcope, C., Zhou, L., Hui, S. L., Peacock, M., & Johnston, C. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119701 · Cited by 455 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundRisk Factors for Osteoporotic Fractures in Elderly Men
Ngugyen, T. V., Eisman, J. A., Kelly, P. J., & Sambroak, P. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008920 · Cited by 442
Periosteal Bone Formation — A Neglected Determinant of Bone Strength
Seeman, E. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038101 · Cited by 433 · cited 1×
“Androgens appear to increase periosteal bone formation and cortical thickness, thereby increasing bone strength [71].”
BackgroundBellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 430 · cited 1×
“Animal studies have consistently demonstrated an integral role for androgen receptor stimulation in maintaining normal bone turnover [63–65], and testosterone has been shown to prevent orchidectomy-induced bone loss in mice lacking the estrogen receptor-a [66].”
BackgroundEstrogen receptor specificity in the regulation of skeletal growth and maturation in male mice
Vidal, O., Lindberg, M. K., Hollberg, K., Baylink, D. J., Andersson, G., Lubahn, D. B., Mohan, S., Gustafsson, J.-Å., & Ohlsson, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5474 · Cited by 386 · cited 1×
“For example, studies performed on mice with targeted inactivation of the genes encoding the aromatase enzyme and estrogen receptor-a clearly reveal a regulatory role for estradiol in the male skeleton [43–48], as do animal studies involving pharmacological aromatase blockade [49, 50].”
BackgroundOutcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis
Hajjar, R. R., Kaiser, F. E., & Morley, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3793 · Cited by 325
Secondary Hypogonadism in Older Men: Its Relation to Impotence*
KORENMAN, S. G., MORLEY, J. E., MOORADIAN, A. D., DAVIS, S. S., KAISER, F. E., SILVER, A. J., VIOSCA, S. P., & GARZA, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-963 · Cited by 320 · cited 1×
“Bioavailable testosterone was measured by radioimmunoassay after ammonium sulfate precipitation as described previously [19,20].”
MethodSuppressive function of androgen receptor in bone resorption
Kawano, H., Sato, T., Yamada, T., Matsumoto, T., Sekine, K., Watanabe, T., Nakamura, T., Fukuda, T., Yoshimura, K., Yoshizawa, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533500100 · Cited by 317 · cited 1×
“For example, studies performed on mice with targeted inactivation of the genes encoding the aromatase enzyme and estrogen receptor-a clearly reveal a regulatory role for estradiol in the male skeleton [43–48], as do animal studies involving pharmacological aromatase blockade [49, 50].”
BackgroundMAILLEFERT, J. F., SIBILIA, J., MICHEL, F., SAUSSINE, C., JAVIER, R. M., & TAVERNIER, C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61639-2 · Cited by 308 · cited 1×
“Gonadal steroid deprivation increases bone resorption relative to bone formation leading to bone loss [36–38].”
BackgroundAmin, S., Zhang, Y., Sawin, C. T., Evans, S. R., Hannan, M. T., Kiel, D. P., Wilson, P. W. F., & Felson, D. T. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00010 · Cited by 293 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundDifferential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283 · cited 2×
“Selectively lowering estrogen levels in men increases bone resorption [21,22] and is expected to cause bone loss if maintained for a prolonged period of time.”
BackgroundSelf-citationBURRIS, A. S., BANKS, S. M., CARTER, C. S., DAVIDSON, J. M., & SHERINS, R. J. (1992) · Journal of Andrology · doi:10.1002/j.1939-4640.1992.tb00319.x · Cited by 259 · cited 1×
“Hypogonadism in elderly men is associated with a variety of physiological changes including decreased libido, fatigue, decreased intellectual ability, decreased lean body mass, increased fat mass, and osteoporosis [5–10].”
BackgroundLongitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men
Gennari, L., Merlotti, D., Martini, G., Gonnelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030736 · Cited by 235 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundEspeland, M. A., Rapp, S. R., Shumaker, S. A., Brunner, R., Manson, J. E., Sherwin, B. B., Hsia, J., Margolis, K. L., Hogan, P. E., Wallace, R., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000140471.21348.f1 · Cited by 222 · cited 1×
“Furthermore, because estrogen replacement increases cardiovascular risk [28,29] and impairs cognitive function [30–32] in women, it is possible that aromatase inhibition may have unique benefits compared with traditional testosterone replacement in men in these areas as well.”
BackgroundBone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency
Vanderschueren, D. (1992) · Endocrinology · doi:10.1210/en.130.5.2906 · Cited by 222 · cited 1×
“Animal studies have consistently demonstrated an integral role for androgen receptor stimulation in maintaining normal bone turnover [63–65], and testosterone has been shown to prevent orchidectomy-induced bone loss in mice lacking the estrogen receptor-a [66].”
BackgroundBarrett-Connor, E., Mueller, J. E., von Mühlen, D. G., Laughlin, G. A., Schneider, D. L., & Sartoris, D. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6327 · Cited by 216 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundMarcus, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1032 · Cited by 213 · cited 1×
“Furthermore, BMD is lower in adults with complete androgen insensitivity syndrome (caused by inactivating mutations in the androgen receptor gene) than in age-matched controls of either sex [67,68].”
BackgroundCorrelates of osteoprotegerin levels in women and men.
Khosla, S., Arrighi, H. M., Melton, III, Atkinson, E. J., O'Fallon, W. M., Dunstan, C., & Riggs, B. L. (2002) · Osteoporosis International · doi:10.1007/s001980200045 · Cited by 205 · cited 1×
“flicting results [75,76].”
Bone Has a Sexually Dimorphic Response to Aromatase Deficiency
Öz, O. K., Zerwekh, J. E., Fisher, C., Graves, K., Nanu, L., Millsaps, R., & Simpson, E. R. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.507 · Cited by 194 · cited 1×
“For example, studies performed on mice with targeted inactivation of the genes encoding the aromatase enzyme and estrogen receptor-a clearly reveal a regulatory role for estradiol in the male skeleton [43–48], as do animal studies involving pharmacological aromatase blockade [49, 50].”
BackgroundImportance of Gonadal Steroids to Bone Mass in Men with Hyperprolactinemic Hypogonadism
Greenspan, S. L., Oppenheim, D. S., & Klibanski, A. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-7-526 · Cited by 191 · cited 1×
“Androgen replacement clearly increases BMD in profoundly hypogonadal men [39–42] and older men with mild hypogonadism (such as those enrolled in this study) [11].”
BackgroundKhosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191 · cited 1×
“flicting results [75,76].”
Hormonal and Biochemical Parameters in the Determination of Osteoporosis in Elderly Men*
Center, J. R., Nguyen, T. V., Sambrook, P. N., & Eisman, J. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6051 · Cited by 189 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundTestosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study
Jackson, J. A., Riggs, M. W., & Spiekerman, A. M. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199207000-00003 · Cited by 183
Androgen–Behavior Correlations in Hypogonadal Men and Eugonadal Men
Alexander, G. M., Swerdloff, R. S., Wang, C., Davidson, T., McDonald, V., Steiner, B., & Hines, M. (1998) · Hormones and Behavior · doi:10.1006/hbeh.1998.1439 · Cited by 180 · cited 1×
“Hypogonadism in elderly men is associated with a variety of physiological changes including decreased libido, fatigue, decreased intellectual ability, decreased lean body mass, increased fat mass, and osteoporosis [5–10].”
BackgroundMcPherson, S. J. (2001) · Endocrinology · doi:10.1210/en.142.6.2458 · Cited by 176 · cited 1×
“For example, it has been suggested that estrogens may play a role in the development of both prostate cancer and benign prostatic hyperplasia [23–27].”
BackgroundOngphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N., & Chailurkit, L. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00631.x · Cited by 174 · cited 1×
“receptor-a gene or the aromatase gene are osteoporotic [51–53], and numerous epidemiological studies have reported associations between serum estradiol levels and BMD or fracture in adult men [54–62].”
BackgroundGoldray, D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.288 · Cited by 174 · cited 1×
“Gonadal steroid deprivation increases bone resorption relative to bone formation leading to bone loss [36–38].”
BackgroundORWOLL, E. S. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70009-8 · Cited by 172
The structural and biomechanical basis of the gain and loss of bone strength in women and men
Seeman, E. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00078-6 · Cited by 163 · cited 1×
“Cortical architecture may be an important determinant of bone strength [70].”
BackgroundVanderschueren, D. (1997) · Endocrinology · doi:10.1210/en.138.6.2301 · Cited by 151
Effects of Aromatase Inhibition in Elderly Men with Low or Borderline-Low Serum Testosterone Levels
Leder, B. Z., Rohrer, J. L., Rubin, S. D., Gallo, J., & Longcope, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031467 · Cited by 149 · cited 4×
“The details of subject selection and randomization have been previously described [18].”
BackgroundSelf-citationOestrogens and prostate cancer.
Risbridger, G. P., Bianco, J. J., Ellem, S. J., & McPherson, S. J. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100187 · Cited by 139
Cross-sectional assessment of age-related bone loss in men: the MINOS study
Szulc, P., Marchand, F., Duboeuf, F., & Delmas, P. D. (2000) · Bone · doi:10.1016/s8756-3282(99)00255-0 · Cited by 137
Movérare, S., Venken, K., Eriksson, A.-L., Andersson, N., Skrtic, S., Wergedal, J., Mohan, S., Salmon, P., Bouillon, R., Gustafsson, J.-Å., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233084100 · Cited by 131 · cited 1×
“For example, studies performed on mice with targeted inactivation of the genes encoding the aromatase enzyme and estrogen receptor-a clearly reveal a regulatory role for estradiol in the male skeleton [43–48], as do animal studies involving pharmacological aromatase blockade [49, 50].”
BackgroundSex- and Age-Related Response to Aromatase Deficiency in Bone
Miyaura, C., Toda, K., Inada, M., Ohshiba, T., Matsumoto, C., Okada, T., Ito, M., Shizuta, Y., & Itô, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4246 · Cited by 114
Taxel, P., Kennedy, D. G., Fall, P. M., Willard, A. K., Clive, J. M., & Raisz, L. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7541 · Cited by 111 · cited 1×
“In an uncontrolled study of 15 eugonadal elderly men, anastrozole administration (2 mg daily) increased C-telopeptide of type 1 collagen by 11%, but did not increase urinary NTX excretion [69].”
BackgroundThe measurement of sex steroid binding globulin by differential ammonium sulphate precipitation
O'connor, S., Baker, H. W. G., Dulmanis, A., & Hudson, B. (1973) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(73)90002-2 · Cited by 107 · cited 1×
“Bioavailable testosterone was measured by radioimmunoassay after ammonium sulfate precipitation as described previously [19,20].”
MethodBehavioural correlates of testosterone
Christiansen, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_3 · Cited by 103
Vandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., Bouillon, R., & Vanderschueren, D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.11.2080 · Cited by 100 · cited 1×
“Animal studies have consistently demonstrated an integral role for androgen receptor stimulation in maintaining normal bone turnover [63–65], and testosterone has been shown to prevent orchidectomy-induced bone loss in mice lacking the estrogen receptor-a [66].”
BackgroundDr. Diamond, T., Stiel, D., & Posen, S. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060108 · Cited by 96 · cited 1×
“Androgen replacement clearly increases BMD in profoundly hypogonadal men [39–42] and older men with mild hypogonadism (such as those enrolled in this study) [11].”
BackgroundAltered Bone Mineral Density in Patients with Complete Androgen Insensitivity Syndrome
Bertelloni, S., Baroncelli, G. I., Federico, G., Cappa, M., Lala, R., & Saggese, G. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023296 · Cited by 91 · cited 1×
“Furthermore, BMD is lower in adults with complete androgen insensitivity syndrome (caused by inactivating mutations in the androgen receptor gene) than in age-matched controls of either sex [67,68].”
BackgroundAromatization of androgens is important for skeletal maintenance of aged male rats
Vanderschueren, D., Herck, E. V., Coster, R. D., & Bouillon, R. (1996) · Calcified Tissue International · doi:10.1007/s002239900106 · Cited by 87
Estrogenic effects on prostatic differentiation and carcinogenesis
Cunha, G. R., Wang, Y. Z., Hayward, S. W., & Risbridger, G. P. (2001) · Reproduction Fertility and Development · doi:10.1071/rd01010 · Cited by 86 · cited 1×
“For example, it has been suggested that estrogens may play a role in the development of both prostate cancer and benign prostatic hyperplasia [23–27].”
BackgroundTestosterone Prevents Orchidectomy-Induced Bone Loss in Estrogen Receptor-α Knockout Mice
Vandenput, L., EDERVEEN, A. G. H., Erben, R. G., Stähr, K., Swinnen, J. V., Herck, E. V., Verstuyf, A., Boonen, S., Bouillon, R., & Vanderschueren, D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5101 · Cited by 84 · cited 1×
“Animal studies have consistently demonstrated an integral role for androgen receptor stimulation in maintaining normal bone turnover [63–65], and testosterone has been shown to prevent orchidectomy-induced bone loss in mice lacking the estrogen receptor-a [66].”
BackgroundBone Loss and Bone Size After Menopause
Ahlborg, H. G., Johnell, O., Turner, C. H., Rannevik, G., & Karlsson, M. K. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000109262.37864.99 · Cited by 80 · cited 1×
“In contrast, estrogens may decrease periosteal bone formation [72].”
BackgroundTwo Different Pathways for the Maintenance of Trabecular Bone in Adult Male Mice
Lindberg, M. K., Movérare, S., Skrtic, S., Alatalo, S., Halleen, J., Mohan, S., Gustafsson, J.-Å., & Ohlsson, C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.555 · Cited by 77 · cited 1×
“For example, studies performed on mice with targeted inactivation of the genes encoding the aromatase enzyme and estrogen receptor-a clearly reveal a regulatory role for estradiol in the male skeleton [43–48], as do animal studies involving pharmacological aromatase blockade [49, 50].”
BackgroundHofbauer, L., Hicok, K., Chen, D., & Khosla, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470269 · Cited by 72 · cited 1×
“[73,74].”
Habenicht, U., Schwarz, K., Neumann, F., & El Etreby, M. F. (1987) · The Prostate · doi:10.1002/pros.2990110404 · Cited by 63 · cited 1×
“For example, it has been suggested that estrogens may play a role in the development of both prostate cancer and benign prostatic hyperplasia [23–27].”
BackgroundFinkelstein, J. S. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_6 · Cited by 37
Self-citationSuzuki, K., Takezawa, Y., Suzuki, T., Honma, S., & Yamanaka, H. (1994) · The Prostate · doi:10.1002/pros.2990250402 · Cited by 34
Bhasin, S., Bross, R., Storer, T. W., & Casaburi, R. H. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_7 · Cited by 27
Gonadal Steroids and the Skeleton in Men: Clinical Aspects
Leder, B. Z., & Finkelstein, J. S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-278-3:393 · Cited by 7 · cited 1×
“Hypogonadism is one of the most important risk factors for osteoporosis in men [34,35].”
BackgroundSelf-citation
Cited by
Manolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
“males (11), especially because similar small differences do not seem to cause BMD differences in pre- or perimenopausal women (12).”
BackgroundEstrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
A concise review of testosterone and bone health
Mohamad, N. V., Soelaiman, I.-N., & Chin, K.-Y. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s115472 · Cited by 292
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177
Metadata
- Authors
- Leder, B. Z., & Finkelstein, J. S.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Leder, Benjamin Z.
- Venue
- Osteoporosis International
- Published
- 2005-04-23
- Volume
- 16
- Issue
- 12
- Pages
- 1487-1494
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2017930983
- Semantic Scholar
- 0d9c8160bde1b2e73e7bd92c06f1a5a75080cbd7
- Cited by
- 44
- References
- 78
- Citations by year
- 2024: 1 · 2022: 4 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 11 · 2015: 1 · 2014: 3 · 2012: 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK002759)
- National Center for Research Resources (M01RR001066, K23RR016310, RR-1066)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- anastrozole, aromatase inhibitors, male hypogonadism, older men, bone metabolism, testosterone, estradiol, bone turnover markers, bone mineral density, osteoprotegerin, N-telopeptide, deoxypyridinoline, osteocalcin, androgen production, bone resorption, bone formation, hormone replacement therapy
- MeSH terms
- Anastrozole, Aged, Bone and Bones, Bone Resorption, Estradiol, Glycoproteins, Humans, Hypogonadism, Male, Nitriles, Testosterone, Triazoles, Biomarkers, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Aromatase Inhibitors, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.